MicroRNA‑10b expression in node‑negative breast cancer‑correlation with metastasis and angiogenesis

Liu,Xia; Guan,Yong; Wang,Li; Niu,Yun

doi:10.3892/ol.2017.6914

MicroRNA‑10b expression in node‑negative breast cancer‑correlation with metastasis and angiogenesis

Authors:
- Xia Liu
- Yong Guan
- Li Wang
- Yun Niu
View Affiliations

Affiliations: Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China
Published online on: September 8, 2017 https://doi.org/10.3892/ol.2017.6914
Pages: 5845-5852
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Metastasis accounts for the majority of cases of mortality in patients with axillary lymph node‑negative (ANN) breast cancer. Angiogenesis is an essential component of the metastatic pathway. Studies regarding microRNA (miR)‑10b expression in patients with ANN breast cancer and the function of angiogenesis in breast cancer remain scarce. The present study was performed in order to determine the biological significance of miR‑10b, and investigate the association between miR‑10b and microvessel density (MVD) measured in ANN breast cancer. miR‑10b expression and immunohistochemical analysis for MVD were assessed in 195 patients with ANN of invasive ductal carcinoma, including 65 cases with distant metastasis ‘poor group’, and 130 cases without any recurrence ‘good group’. miR‑10b expression was higher in the ‘poor group’ (73.8%) compared with that in the ‘good group’ (51.5%; P=0.003). Multivariate logistic regression demonstrated that miR‑10b retained independent prognostic significance for distant metastasis along with MVD and vascular invasion. Among 195 patients, miR‑10b expression was significantly associated with tumor grade, tumor size and molecular subtypes (P<0.05). In addition, miR‑10b expression was positively associated with the MVD count (r=0.370; P<0.001), tumor grade (r=0.168; P=0.019) and tumor size (r=0.175; P=0.014). The results of the current study suggest that miR‑10b is a useful marker for predicting metastasis and angiogenesis in ANN breast cancer.

View Figures

View References

1	Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet. 365:1687–1717. 2005. View Article : Google Scholar : PubMed/NCBI
2	Metzger-Filho O, Sun Z, Viale G, Price KN, Crivellari D, Snyder RD, Gelber RD, Castiglione-Gertsch M, Coates AS, Goldhirsch A and Cardoso F: Patterns of recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: Results from international breast cancer study group trials VIII and IX. J Clin Oncol. 31:3083–3090. 2013. View Article : Google Scholar : PubMed/NCBI
3	Fisher CS, Cole DJ, Mitas M, Garrett-Meyer E, Metcalf JS, Gillanders WE, Mikhitarian K, Urist MM, Mann GB, Doherty G, et al: Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: A final analysis of a prospective multi-institutional cohort study. Ann Surg Oncol. 17 Suppl 3:S312–S320. 2010. View Article : Google Scholar
4	Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
5	Taft RJ, Glazov EA, Cloonan N, Simons C, Stephen S, Faulkner GJ, Lassmann T, Forrest AR, Grimmond SM, Schroder K, et al: Tiny RNAs associated with transcription start sites in animals. Nat Genet. 41:572–578. 2009. View Article : Google Scholar : PubMed/NCBI
6	Goswami RS, Waldron L, Machado J, Cervigne NK, Xu W, Reis PP, Bailey DJ, Jurisica I, Crump MR and Kamel-Reid S: Optimization and analysis of a quantitative real-time PCR-based technique to determine microRNA expression in formalin-fixed paraffin-embedded samples. BMC Biotechnol. 10:472010. View Article : Google Scholar : PubMed/NCBI
7	Plummer PN, Freeman R, Taft RJ, Vider J, Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, et al: MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res. 73:341–352. 2013. View Article : Google Scholar : PubMed/NCBI
8	Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L, Pan Q, He ML and Li XP: MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett. 299:29–36. 2010. View Article : Google Scholar : PubMed/NCBI
9	Setoyama T, Zhang X, Natsugoe S and Calin GA: microRNA-10b: A new marker or the marker of pancreatic ductal adenocarcinoma? Clin Cancer Res. 17:5527–5529. 2011. View Article : Google Scholar : PubMed/NCBI
10	Jiang H, Liu J, Chen Y, Ma C, Li B and Hao T: Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer. Cancer Med. 5:2932–2941. 2016. View Article : Google Scholar : PubMed/NCBI
11	Ma L, Teruya-Feldstein J and Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
12	Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology. 19:403–410. 1991. View Article : Google Scholar : PubMed/NCBI
13	Rosen PP and Oberman HA: Tumors of the mammary gland. In: Atlas of Tumor Pathology. 3rd series, fascicle 7Armed Forces Institute of Pathology. Washington, DC: 1993
14	Niu Y, Fu X, Lv A, Fan Y and Wang Y: Potential markers predicting distant metastasis in axillary node-negative breast carcinoma. Int J Cancer. 98:754–760. 2002. View Article : Google Scholar : PubMed/NCBI
15	Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, et al: Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet. 379:815–822. 2012. View Article : Google Scholar : PubMed/NCBI
16	Koo CL, Kok LF, Lee MY, Wu TS, Cheng YW, Hsu JD, Ruan A, Chao KC and Han CP: Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study. J Transl Med. 7:252009. View Article : Google Scholar : PubMed/NCBI
17	Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, et al: American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 28:2784–2795. 2010. View Article : Google Scholar : PubMed/NCBI
18	Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, et al: American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 25:118–145. 2007. View Article : Google Scholar : PubMed/NCBI
19	Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, et al: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 101:736–750. 2009. View Article : Google Scholar : PubMed/NCBI
20	Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B and Senn HJ: Panel members: Personalizing the treatment of women with early breast cancer: Highlights of the st Gallen International Expert consensus on the primary therapy of early breast cancer. Ann Oncol. 24:2206–2223. 2013. View Article : Google Scholar : PubMed/NCBI
21	Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 84:1875–1887. 1992. View Article : Google Scholar : PubMed/NCBI
22	Ma L: Role of miR-10b in breast cancer metastasis. Breast Cancer Res. 12:2102010. View Article : Google Scholar : PubMed/NCBI
23	Shen X, Fang J, Lv X, Pei Z, Wang Y, Jiang S and Ding K: Heparin impairs angiogenesis through inhibition of microRNA-10b. J Biol Chem. 286:26616–26627. 2011. View Article : Google Scholar : PubMed/NCBI
24	van der Hage JA, Mieog JS, van de Velde CJ, Putter H, Bartelink H and van de Vijver MJ: Impact of established prognostic factors and molecular subtype in very young breast cancer patients: Pooled analysis of four EORTC randomized controlled trials. Breast Cancer Res. 13:R682011. View Article : Google Scholar : PubMed/NCBI
25	Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM and Rosenberg A: MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol. 219:214–221. 2009. View Article : Google Scholar : PubMed/NCBI
26	Zhao FL, Hu GD, Wang XF, Zhang XH, Zhang YK and Yu ZS: Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer. J Int Med Res. 40:859–866. 2012. View Article : Google Scholar : PubMed/NCBI
27	Keyhani E, Muhammadnejad A, Behjati F, Sirati F, Khodadadi F, Karimlou M, Moghaddam FA and Pazhoomand R: Angiogenesis markers in breast cancer-potentially useful tools for priority setting of anti-angiogenic agents. Asian Pac J Cancer Prev. 14:7651–7656. 2013. View Article : Google Scholar : PubMed/NCBI
28	Niemiec J, Adamczyk A, Ambicka A, Mucha-Małecka A, Wysocki W, Mituś J and Ryś J: Lymphangiogenesis assessed using three methods is related to tumour grade, breast cancer subtype and expression of basal marker. Pol J Pathol. 63:165–171. 2012. View Article : Google Scholar : PubMed/NCBI
29	Muhammadnejad S, Muhammadnejad A, Haddadi M, Oghabian MA, Mohagheghi MA, Tirgari F, Sadeghi-Fazel F and Amanpour S: Correlation of microvessel density with nuclear pleomorphism, mitotic count and vascular invasion in breast and prostate cancers at preclinical and clinical levels. Asian Pac J Cancer Prev. 14:63–68. 2013. View Article : Google Scholar : PubMed/NCBI
30	Plummer PN, Freeman R, Taft RJ, Vider J, Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, et al: MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res. 73:341–352. 2013. View Article : Google Scholar : PubMed/NCBI
31	Myers C, Charboneau A, Cheung I, Hanks D and Boudreau N: Sustained expression of homeobox D10 inhibits angiogenesis. Am J Pathol. 161:2099–2109. 2002. View Article : Google Scholar : PubMed/NCBI